Press Releases Sanofi Nasdaq

Equities

SNY

US80105N1054

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
50.36 ^USD	+2.88%		+2.75%	+1.27%

May. 22	Bristol Myers, Sanofi liability in Hawaii Plavix case grows to $916 million	RE
May. 21	Sanofi Partners with Microsoft-Backed OpenAI, Formation Bio to Develop Drugs with AI	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

INNATE PHARMA SA - CLARIFICATION REGARDING SAR443579 DESIGNATION	May. 22	AQ
Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration	May. 22	AQ
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit	May. 22	AQ
Press Release: Sanofi, Formation Bio and OpenAI announce first-in-class AI collaboration	May. 21	GL
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM	May. 20	GL
Enabling The "Full Scope" Of Claims In View Of The Supreme Court's Decision In Amgen	May. 13	AQ
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines	May. 13	AQ
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	May. 13	AQ
Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty	May. 13	GL
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines	May. 10	GL
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations	May. 02	GL
Press Release: Annual General Meeting of April 30, 2024	Apr. 30	GL
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024	Apr. 30	AQ
Media Update: New data presented at ATS demonstrate Sanofi’s leadership in advancing potential new therapies for patients with immune-mediated respiratory diseases	Apr. 26	PU
Sanofi Q1 robust 7% sales growth driven by launches, underpins full-year guidance	Apr. 26	AQ
Sanofi: Q1 Earnings Snapshot	Apr. 25	AQ
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance	Apr. 25	GL
AusBiotech announces incoming CEO	Apr. 24	AQ
Sanofi - Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia	Apr. 24	AQ
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia	Apr. 23	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Sanofi’s healthy Q1 performance hailed by markets

April 25, 2024 at 07:58 am EDT

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm EST